- – PB&B owns 100% of its IP; no royalty nor equity stakes taken by academic partners or third parties on PB&B’s IP
- – Recession proof global market with double digit growth
- – Platform technology with applications in facial aging & body remodeling with a strong IP position – Medical Aesthetics is a field with the least new technology companies & innovations
- – Novel medical Aesthetic technology typically acquired in the billion dollar range
- – PB&B considered by Plastic Surgeons at the technology the replacement to autologous fat transfer procedures
- – PB&B gained the financial & logistical support of the Swiss federal & local state government economic promotion office for scientific innovation. PB&B has won multiple national & international prizes & nominations for its scientific innovations worldwide.